A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancer

V. Wang, M.S. Geybels, K.M. Jordahl, T. Gerke, A. Hamid, K.L. Penney, S.C. Markt, M. Freedman, M. Pomerantz, G.S.M. Lee, H. Rana, D. Bornigen, T.R. Rebbeck, C. Huttenhower, R.A. Eeles, J.L. Stanford, S.I. Berndt, F. Claessens, K.D. Sorensen, J.Y. ParkA. Vega, N. Usmani, L. Mucci, C.J. Sweeney*, Consortium Practical, Practical Consortium

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)683-693
Number of pages11
JournalProstate
Volume81
Issue number10
DOIs
Publication statusPublished - 1 Jul 2021

Keywords

  • African ancestry
  • nuclear factor kappa B
  • single nucleotide polymorphisms
  • SNPs
  • FACTOR-KAPPA-B
  • GENOME-WIDE ASSOCIATION
  • ANDROGEN DEPRIVATION
  • SUSCEPTIBILITY LOCI
  • RISK
  • MEN
  • RADIOTHERAPY
  • VARIANTS
  • STATISTICS
  • MORTALITY

Cite this